Providing hope to cholangiocarcinoma patients by raising and investing in breakthrough research to prevent and cure cholangiocarcinoma, and providing support as they navigate their journey through mentoring, advocacy, love and prayer.
2019 Capital Hill Day Advocating for Liver Cancer
My first Capital Hill Day advocating for Liver Cancer. We had the opportunity to speak with senators and congressmen and attend a congressional briefing. What an incredible opportunity and I can’t wait to go back.
A bill has been introduced this year that can curb the rising epidemic of liver cancer. The LIVER Act of 2019, H.R. 3016, is sponsored by Congresswoman Nydia Velázquez (NY) and would drive several public health initiatives that will help people of all ages, lifestyles, and ethnic backgrounds reduce their risk for liver cancer and related illnesses by enhancing the federal government’s prevention, education, and disease surveillance capabilities while empowering local entities to promote treatment and raise awareness.
Specifically, the bill properly adjusts the priority of liver cancer and illnesses within NIH by creating a Liver Disease Division within National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
The bill expands, intensifies, and coordinates the activities of NCI with respect to research on liver cancer and liver disease. Additionally, it creates two new grant programs at the Centers for Disease Control (CDC)
Senator Todd Young
Lisa with Donna Cryer, Global Liver Institute Founder